Cetrorelix
Product Images NDC 17478-793

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Cetrorelix (NDC 17478-793). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Akorn, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Cet03 0003 01)

Chemical structure of Cetrorelix, showing its detailed molecular arrangement, including peptide bonds, functional groups, and side chains. The structure includes a note indicating association with AcOH.*

FDA Label Image

Figure (Cet03 0003 02)

An instructional illustration showing how to hold an injection pen device in one hand while using the other hand to prepare or operate it. The image emphasizes proper hand placement on the pen for administration of medication.*

FDA Label Image

Figure (Cet03 0003 03)

An instructional illustration showing three steps for preparing and administering an injection. It includes a vial, a swab packet, a syringe filled with liquid, and a needle separate from the syringe, likely demonstrating how to use the syringe to draw medication from the vial and then attach the needle for injection.*

FDA Label Image

Figure (Cet03 0003 04)

An instructional two-panel illustration showing how to remove a protective seal from a vial. The left panel depicts hands lifting the central part of the vial cap upward. The right panel shows peeling away the outer foil seal from the vial top.*

FDA Label Image

Figure (Cet03 0003 05)

An instructional diagram showing a syringe with a needle cap being removed by rotating the cap upward. The image illustrates proper preparation of the syringe for injection, likely related to the Cetrorelix product by Akorn.*

FDA Label Image

Figure (Cet03 0003 06)

An instructional diagram depicting a syringe being inserted into the top of a vial, indicated by an arrow. This image likely relates to the preparation or administration of Cetrorelix, although no specific text or labels appear on the illustration.*

FDA Label Image

Figure (Cet03 0003 07)

Illustration showing a hand holding a syringe above a vial, appearing to demonstrate the process of drawing medication from the vial into the syringe. The image is instructional, related to medication preparation or administration.*

FDA Label Image

Figure (Cet03 0003 08)

An instructional diagram showing the assembly of a syringe and vial. The image features a vial with a cap at the top, connected by a downward arrow to a syringe below, indicating the direction to attach or prepare the syringe for use.*

FDA Label Image

Figure (Cet03 0003 09)

An instructional illustration showing the preparation of a syringe. It depicts removing a cap or cover from the syringe needle by pulling and twisting motions indicated by arrows. The syringe is shown with attached needle, emphasizing steps to ready it for use.*

FDA Label Image

Figure (Cet03 0003 10)

An instructional illustration showing a syringe with its cap partially removed, indicated by an arrow pointing upwards, suggesting the step of removing the needle cap before use.*

FDA Label Image

Figure (Cet03 0003 11)

An instructional diagram showing two steps for using a syringe with a vial. The first step depicts hand placement holding the vial upside down. The second step demonstrates drawing liquid into the syringe, suggesting preparation for injection.*

FDA Label Image

Figure (Cet03 0003 12)

An instructional illustration showing a hand holding a syringe above a container labeled with a biohazard symbol, demonstrating proper disposal of the syringe into the container. The image relates to safe injection practices but does not show specific product information for Cetrorelix.*

FDA Label Image

Principal Display Panel Text For Container Label (Cet03 0003 13)

Label for Cetrorelix Acetate for Injection 0.25 mg by Akorn, NDC 17478-793-12. It states the product is sterile, for subcutaneous use only, and includes one vial with lyophilized powder, one pre-filled syringe with diluent, and needles. The label notes storage conditions (2-8°C), manufacturing by GP Pharm S.A. in Spain, and distribution by Akorn Operating Company LLC in Illinois, USA.*

FDA Label Image

Principal Display Panel Text For Carton Label (Cet03 0003 14)

Cetrorelix Acetate for Injection 0.25 mg carton label by Akorn. The label lists contents as one vial with lyophilized powder for reconstitution, one pre-filled syringe with diluent, one 20-gauge needle, and one 27-gauge needle. It states the product is sterile for subcutaneous use and prescription only, with storage instructions to refrigerate at 2-8°C. The label includes manufacturer and distributor details and the NDC 17478-793-12.*

FDA Label Image

Principal Display Panel Text For Container Label (Cet03 0003 15)

Cetrorelix Acetate for Injection 0.25 mg vial label indicating sterile subcutaneous use, storage instructions including refrigeration at 2-8°C, distributed by Akorn, and made in Spain. Includes NDC and lot number details.*

FDA Label Image

Principal Display Panel Text For Syringe Label (Cet03 0003 16)

Label for 1 mL Prefilled Sterile Water for Injection, USP with pH 5-8. Distributed by Akorn in Gurnee, IL, and made in Spain. The label includes the NDC 17478-795-01, space for lot number and expiration date, and is marked Rx Only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.